HealthDay Reports: More COVID-19 Tests Arrive, But Bottlenecks Persist
Though there are now more COVID-19 tests available, other issues are causing roadblocks in the chain for adequate testing.
More COVID-19 Tests Arrive, But Bottlenecks Persist
TUESDAY, April 7, 2020 (HealthDay News) -- U.S. pathology labs are now awash in COVID-19 tests, with more than two dozen rapid tests on the market thanks to expedited approval by the U.S. Food and Drug Administration, infectious disease experts say.
Despite this, laboratories are still struggling with shortages that hamper their ability to get ahead of the ever-expanding pandemic.
"Early in the outbreak testing was limited, and now we have multiple tests available to us," said Dr. Kim Hanson, an infectious disease specialist with University of Utah Health in Salt Lake City. "The main limitation we're facing now is having shortages of other pieces around the test itself."